Related Experiment Video
Updated: May 4, 2026

3D Microtissues for Injectable Regenerative Therapy and High-throughput Drug Screening
Published on: October 4, 2017
Precision theranostics in cervical Cancer: Harnessing stimuli-responsive hydrogels for tumor
Yu Zhang1,2,3, Yueda Lu1,2,3, Sidi Li2
1Department of Obstetrics and Gynecology, The First Affiliated Hospital of Anhui Medical University, No 218 Jixi Road, Hefei, 230022, PR China.
Abstract:
Cervical cancer continues to pose a significant threat to women's health worldwide, with conventional therapies often limited by drug resistance and systemic toxicity. Stimuli-responsive hydrogels have recently emerged as promising platforms in precision oncology, owing to their ability to enable spatiotemporally controlled drug delivery, integrate multimodal theranostic functions, and dynamically interact with the tumor microenvironment (TME). This review highlights the stimuli-responsive hydrogels as precision theranostic platforms capable of targeting the unique TME of cervical cancer. We systematically categorize hydrogel systems based on their response mechanisms-pH, temperature, enzymes, light, magnetic fields, and redox conditions-and directly align these with clinical applications such as chemotherapy, gene therapy, immunotherapy, and real-time diagnostics. We further explore the integration of advanced technologies including 4D printing, organoid models, and artificial intelligence (AI) for personalized treatment planning and dynamic adaptability. By offering a comprehensive and application-oriented perspective, this review provides innovative insights into the design of smart hydrogels that enhance therapeutic precision, reduce off-target effects, and improve diagnostic sensitivity in cervical cancer.
Insights
Stimuli-responsive hydrogels offer precise cervical cancer treatment by targeting the tumor microenvironment. These smart materials enhance drug delivery, diagnostics, and reduce side effects for better patient outcomes.
Area of Science:
- Biomaterials Science
- Oncology
- Nanotechnology
Background:
- Cervical cancer presents a global health challenge, with conventional treatments facing limitations like drug resistance and toxicity.
- Stimuli-responsive hydrogels are emerging as advanced platforms for precision oncology.
Purpose of the Study:
- To review stimuli-responsive hydrogels as precision theranostic platforms for cervical cancer.
- To highlight their ability to target the unique tumor microenvironment (TME).
Main Methods:
- Systematic categorization of hydrogel systems based on response mechanisms (pH, temperature, enzymes, light, magnetic fields, redox).
- Alignment of hydrogel systems with clinical applications: chemotherapy, gene therapy, immunotherapy, and diagnostics.
- Exploration of integrated advanced technologies: 4D printing, organoid models, and artificial intelligence (AI).
Main Results:
- Hydrogels offer spatiotemporally controlled drug delivery and multimodal theranostic functions.
- These platforms dynamically interact with the cervical cancer TME.
- Integration with AI and 4D printing enables personalized treatment and dynamic adaptability.
Conclusions:
- Stimuli-responsive hydrogels represent a promising strategy for enhancing therapeutic precision in cervical cancer.
- These smart materials can reduce off-target effects and improve diagnostic sensitivity.
- This review provides insights into designing advanced hydrogels for improved cervical cancer management.
Related Concept Videos
The Tumor Microenvironment
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy

